Interview
“We have no time to waste,” says Frida Lundmark, Head of Research Policy at Lif, the Swedish association of the research-based pharmaceutical industry.
In the summer of 2024, the Swedish Medical Products Agency was tasked with creating better conditions for clinical trials based on proposals from a government inquiry. Over the coming years, the government is investing SEK 60m annually to establish a new structure and national partnership, SweTrial.
BREAKING